MIRA INFORM REPORT

 

 

Report Date :

15.05.2013

 

IDENTIFICATION DETAILS

 

Name :

LIPTIS EGYPT FOR PHARMACEUTICAL PRODUCTS CO

 

 

Formerly Known As :

LIPTIS EGYPT CO / LIPTIS PHARMACEUTICALS

 

 

Registered Office :

65 Manial Street, El Pasha Square, Manial, Cairo

 

 

Country :

Egypt

 

 

Date of Incorporation :

2004

 

 

Com. Reg. No.:

48828

 

 

Legal Form :

Limited Liability Partnership

 

 

Line of Business :

Manufacturers of pharmaceutical preparations.

 

 

No. of Employees :

250

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

Payment Behaviour :

No Complaints

Litigation :

Clear

 

NOTES:

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – March, 31st, 2013

 

Country Name

Previous Rating

(31.12.2012)

Current Rating

(31.03.2013)

Egypt

A2

A2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

EGYPT - ECONOMIC OVERVIEW

 

Occupying the northeast corner of the African continent, Egypt is bisected by the highly fertile Nile valley, where most economic activity takes place. Egypt's economy was highly centralized during the rule of former President Gamal Abdel NASSER but opened up considerably under former Presidents Anwar EL-SADAT and Mohamed Hosni MUBARAK. Cairo from 2004 to 2008 aggressively pursued economic reforms to attract foreign investment and facilitate GDP growth. Despite the relatively high levels of economic growth in recent years, living conditions for the average Egyptian remained poor and contributed to public discontent. After unrest erupted in January 2011, the Egyptian Government backtracked on economic reforms, drastically increasing social spending to address public dissatisfaction, but political uncertainty at the same time caused economic growth to slow significantly, reducing the government's revenues. Tourism, manufacturing, and construction were among the hardest hit sectors of the Egyptian economy, and economic growth is likely to remain slow during the next several years. The government drew down foreign exchange reserves by more than 50% in 2011 and 2012 to support the Egyptian pound and the dearth of foreign financial assistance - as a result of unsuccessful negotiations with the International Monetary Fund over a multi-billion dollar loan agreement which have dragged on more than 20 months - could precipitate fiscal and balance of payments crises in 2013.

Source : CIA

 


SUMMARY

 

Company Name                         : LIPTIS EGYPT FOR PHARMACEUTICAL PRODUCTS CO

Also Known As                                      : LIPTIS EGYPT CO / LIPTIS PHARMACEUTICALS

Country of Origin                                    : Egypt

Legal Form                                            : Limited Liability Partnership

Registration Date                                   : 2004

Commercial Registration Number            : 48828

Tax Card Number                                   : 431-157-022

Issued Capital                                        : £E 10,000,000

Paid up Capital                                      : £E 10,000,000

Total Workforce                         : 250

Activities                                               : Manufacturers of pharmaceutical preparations.

Financial Condition                                 : Undetermined

Payments                                             : Nothing detrimental uncovered

 

 

 


COMPANY NAME

 

LIPTIS EGYPT FOR PHARMACEUTICAL PRODUCTS CO

 

 

ALSO KNOWN AS

 

LIPTIS EGYPT CO / LIPTIS PHARMACEUTICALS

 

 

ADDRESS

 

Registered & Physical Address

 

Street               : 65 Manial Street

Area                 : El Pasha Square, Manial

Town                 : Cairo

Country : Egypt

 

Telephone         : (20-2) 25310174

Facsimile          : (20-2) 23687847 / 23683423

 

Premises

 

Subject operates from a large suite of offices that are rented and located in the Suburban Business Area of Cairo.

 

Branch Office (s)

 

Location                                                                                              Description

 

6th Industrial Zone, Area B2                                                                    Factory premises

6th of October City

Tel: (20-10) 3333992

 

 

KEY PRINCIPALS

 

Name                                                                                       Position

 

Dr Lotfy Ismail Omar                                                                  Managing Partner

 

Dr Ahmed Samir                                                                        General Manager

 

Nasr Hassan                                                                             Finance Manager

 

Mohamed Alaa                                                                          Administration Manager

 

Mohamed Nabil                                                                          Purchasing Manager

 

Ali Fathy                                                                                   Sales Manager

 

 

LEGAL FORM & OWNERS

 

Date of Establishment  : 2004

 

Legal Form                  : Limited Liability Partnership

 

Commercial Reg. No.  : 48828

 

Tax Card No.               : 431-157-022

 

Issued Capital              : £E 10,000,000

 

Paid up Capital            : £E 10,000,000

 

Name of Shareholder (s)

 

Dr Lotfy Ismail Omar

 

Members of Dr Lotfy Ismail Omar’s family

 

 

OPERATIONS

 

Activities:                     Engaged in the manufacture of pharmaceutical preparations. Subject is currently in the process of launching a new production line for baby milk under licence of Hok Dorf (Switzerland).

 

Import Countries:         Switzerland and Egypt.

 

Subject has a workforce of approximately 250 employees.

 

 

FINANCIAL DATA

 

Companies registered in Egypt are not legally required to make their accounts public and no financial information was released by the company or submitted by outside sources.

 

 

BANKERS

 

Export Development Bank of Egypt

108 Mohi El Din Abu El Ezz Street

Mohandessin

Cairo 11111

Tel: (20-2) 33619005 / 33385877

Fax: (20-2) 33385940 / 33385938

 

 

PAYMENT HISTORY

 

No complaints regarding subject’s payments have been reported.

 

 

GENERAL COMMENTS

 

During the course of this investigation nothing detrimental was uncovered regarding subject’s operating history or the manner in which payments are fulfilled. As such the company is considered to be a fair trade risk.

 

 

 

 


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.54.63

UK Pound

1

Rs.83.67

Euro

1

Rs.71.02

 

INFORMATION DETAILS

 

Report Prepared by :

SDA

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

----

NB

New Business

----

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.